Musaddiq Khan
Director, Clinical Program Operations Eli LillyClinical Trial Design Agenda
12:30 PM PANEL DISCUSSION: VIRTUAL, DECENTRALISED AND HYBRID CLINICAL TRIALS IN LIGHT OF THE CURRENT PANDEMIC
- How is the industry reacting to this shift in leveraging remote strategies?
- How do we balance key factors such as patient centricity, data, regulation, compliance and cost, and should flexibility be the greatest priority?
- What impact is this having on the regulators and how they operate?
- Will remote trials affect data endpoints and to what extent?
- What impact do virtual, decentralised and hybrid trials have on patients and how can we reduce potential burdens?
- How is this influencing patient engagement strategies?
In Partnership With :
QUESTIONS?
Address: IQPC Ltd, 129 Wilton Road,
London SW1V 1JZ
Telephone: 44 (0) 207 368 9300
Fax: 44 (0) 207 368 9301
Email: enquire@iqpc.co.uk
©2024 IQPC. All rights reserved.
